longbridge

Neuphoria Therapeutics

NEUP
2.7600.72% ( -0.020 )
Closed: Nov 9, 16:00:00 (EDT)

All Shareholders

Shareholder Type

  • Public and others57.72%
  • Institutions41.55%
  • Individuals & Insiders0.73%

Major Shareholders

Major Shareholders Latest
Shareholder
Lynx1 Capital Management LP
16.18%875.33K0.00%+0
AdvisorShares Investments, LLC
5.78%312.90K1.11%+59.99K
Coastlands Capital LP
4.22%228.59K2.01%+108.59K
Vanguard Capital Management, LLC
3.83%207.29K1.37%+75.19K
Shay Capital LLC
2.88%155.82K0.07%+4.81K
Balyasny Asset Management L.P.
2.63%142.23K0.02%+45.00
Citadel Advisors LLC
1.34%72.56K0.98%+53.23K
Geode Capital Management, LLC
0.94%50.64K0.02%+1.12K
Ikarian Capital, LLC
0.88%47.44K<0.01%+0
ADAR1 Capital Management, LLC
0.55%30.00K<0.01%+0
Renaissance Technologies LLC
0.47%25.50K--+25.50K
XTX Markets Limited
0.43%23.09K0.43%+23.09K
Hudson River Trading LLC
0.42%22.87K--+22.87K
Jane Street Group, LLC
0.28%14.90K0.28%+14.90K
Boothbay Fund Management, LLC
0.26%14.00K<0.01%+0
Alan FisherIndependent Non-Executive Chair of the Board
0.25%13.57K0.25%+13.57K
Northern Trust Global Investments
0.20%10.61K--+10.61K
MRL Ventures Fund LLC
0.19%10.03K<0.01%+0
Jane RyanIndependent Non-Executive Director
0.13%7.01K0.13%+6.78K
Peter Miles DaviesIndependent Non-Executive Director
0.13%6.91K0.13%+6.78K
© 2026 Longbridge｜Terms of ServicePrivacy Policy